Atherosclerosis in diabetes and insulin resistance

scientific article published on July 2007

Atherosclerosis in diabetes and insulin resistance is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1463-1326.2006.00620.X
P8608Fatcat IDrelease_cflxpb7s3bglrda6wbdtoq4jqa
P698PubMed publication ID17587387

P2093author name stringJane E-B Reusch
Boris B Draznin
P2860cites workRoles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cellsQ22253424
The L-arginine-nitric oxide pathwayQ24304874
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational studyQ24652963
Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylationQ24682735
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) GroupQ27860882
Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrierQ28235057
High-glucose-induced structural changes in the heparan sulfate proteoglycan, perlecan, of cultured human aortic endothelial cellsQ28253845
Inflammation, atherosclerosis, and coronary artery diseaseQ29547232
Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination SurveyQ29614468
The pathobiology of diabetic complications: a unifying mechanismQ29617766
Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarctionQ29618673
Hyperglycaemia-induced superoxide production decreases eNOS expression via AP-1 activation in aortic endothelial cellsQ30434846
Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events.Q30759070
Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cellsQ31660362
PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathwayQ31793810
Mechanisms underlying endothelial dysfunction in diabetes mellitusQ31829307
Overexpression of human heme oxygenase-1 attenuates endothelial cell sloughing in experimental diabetesQ45000328
Effect of pioglitazone on carotid intima-media thickness and arterial stiffness in type 2 diabetic nephropathy patientsQ45064729
Preventative effects of rosiglitazone on restenosis after coronary stent implantation in patients with type 2 diabetes.Q45124478
Hyperlipidemia in concert with hyperglycemia stimulates the proliferation of macrophages in atherosclerotic lesions: potential role of glucose-oxidized LDL.Q45161321
Exercise reduces preexisting atherosclerotic lesions in LDL receptor knock out miceQ45177977
High glucose inhibits apoptosis induced by serum deprivation in vascular smooth muscle cells via upregulation of Bcl-2 and Bcl-xlQ45242127
Expression levels and functional aspects of the hyaluronan receptor CD44. Effects of insulin, glucose, IGF-I, or growth hormone on human arterial smooth muscle cellsQ45286381
Exercise might favor reverse cholesterol transport and lipoprotein clearance: potential mechanism for its anti-atherosclerotic effectsQ46429833
At least 2 distinct pathways generating reactive oxygen species mediate vascular cell adhesion molecule-1 induction by advanced glycation end productsQ46450292
Glucose-induced up-regulation of CD36 mediates oxidative stress and microvascular endothelial cell dysfunction.Q46509014
RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetesQ46631889
Insulin action enhancement normalizes brachial artery vasoactivity in patients with peripheral vascular disease and occult diabetes.Q51566310
Relationship of walking to mortality among US adults with diabetes.Q51666294
Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo : a specific vascular action of insulin.Q54062879
Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group.Q55034145
High glucose induces human endothelial cell apoptosis through a phosphoinositide 3-kinase-regulated cyclooxygenase-2 pathway.Q33210941
Cellular mechanisms of insulin resistance in humansQ33694764
Insulin signaling in the arterial wallQ33694779
Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)Q33764951
Recent advances in our understanding of insulin action and insulin resistanceQ34209698
Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyondQ34282992
Identification of AF-6 and canoe as putative targets for Ras.Q34371134
Diabetes and atherosclerosis: epidemiology, pathophysiology, and managementQ34646074
Hyperglycemia alters PI3k and Akt signaling and leads to endothelial cell proliferative dysfunctionQ35103906
Monocyte chemoattractant protein 1 in obesity and insulin resistanceQ35163496
The potential role of peroxisome proliferator-activated receptors on inflammation in type 2 diabetes mellitus and atherosclerosisQ35212555
Molecular mechanisms of insulin resistance that impact cardiovascular biologyQ35927757
The effect of exercise training on endothelial function in cardiovascular disease in humansQ35987165
Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cellsQ36001244
Proatherosclerotic mechanisms involving protein kinase C in diabetes and insulin resistanceQ36002036
Rho-kinase mediates hyperglycemia-induced plasminogen activator inhibitor-1 expression in vascular endothelial cellsQ37079170
Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitusQ37239783
Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesionsQ37486465
Metformin prevents high-glucose-induced endothelial cell death through a mitochondrial permeability transition-dependent processQ40404137
Insulin regulation of sterol regulatory element-binding protein-1 expression in L-6 muscle cells and 3T3 L1 adipocytesQ40547543
Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproductsQ41009444
Advanced glycation end products, oxidant stress and vascular lesionsQ41375234
Hyperglycemia enhances angiotensin II-induced janus-activated kinase/STAT signaling in vascular smooth muscle cellsQ42479400
Pathological roles of advanced glycation end product receptors SR-A and CD36.Q42812060
Scavenger receptor class B type I-mediated reverse cholesterol transport is inhibited by advanced glycation end productsQ43560094
Diabetes accelerates smooth muscle accumulation in lesions of atherosclerosis: lack of direct growth-promoting effects of high glucose levelsQ43566166
Glucose-induced hyperproliferation of cultured rat aortic smooth muscle cells through polyol pathway hyperactivityQ43611292
Rapid communication: inhibitory effect of pioglitazone on carotid arterial wall thickness in type 2 diabetesQ43666606
The effect of combined aerobic and resistance exercise training on vascular function in type 2 diabetesQ43723172
Diabetes-related changes in cAMP response element-binding protein content enhance smooth muscle cell proliferation and migration.Q43740242
Inhibition of phosphatidylinositol 3-kinase enhances mitogenic actions of insulin in endothelial cellsQ43798535
Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group II: pathogenesis of atherosclerosis in diabetesQ43982332
Obesity accelerates the progression of coronary atherosclerosis in young men.Q44023041
Hyperglycaemia inhibits thymidine incorporation and cell growth via protein kinase C, mitogen-activated protein kinases and nitric oxide in human umbilical vein endotheliumQ44351396
Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trialQ44396155
High glucose alters matrix metalloproteinase expression in two key vascular cells: potential impact on atherosclerosis in diabetes.Q44474834
Increased transvascular low density lipoprotein transport in insulin dependent diabetes: a mechanistic model for development of atherosclerosisQ44574970
Insulin Affects Vascular Smooth Muscle Cell Phenotype and Migration Via Distinct Signaling PathwaysQ44599804
Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidityQ44642265
Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination SurveyQ44693873
Insulin enhances vascular cell adhesion molecule-1 expression in human cultured endothelial cells through a pro-atherogenic pathway mediated by p38 mitogen-activated protein-kinaseQ44755613
Effect of rosiglitazone on common carotid intima-media thickness progression in coronary artery disease patients without diabetes mellitusQ44786820
P433issue4
P921main subjectinsulin resistanceQ1053470
atherosclerosisQ12252367
P304page(s)455-463
P577publication date2007-07-01
P1433published inDiabetes, Obesity and MetabolismQ5270109
P1476titleAtherosclerosis in diabetes and insulin resistance
P478volume9

Reverse relations

cites work (P2860)
Q48099420Association of pulse pressure with left ventricular geometry and function in elderly nonhypertensive patients with diabetes: A 3D speckle tracking echocardiography study.
Q35137148Cardiovascular disease in diabetes: where does glucose fit in?
Q58007771Changes in arginine are inversely associated with type 2 diabetes: A case-cohort study in the PREDIMED trial
Q37011769Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations
Q42522031Cod liver oil supplementation improves cardiovascular and metabolic abnormalities in streptozotocin diabetic rats
Q26827620Diabetes and cardiovascular disease: changing the focus from glycemic control to improving long-term survival
Q34830905Diabetes-related microvascular and macrovascular diseases in the physical therapy setting
Q21245065Dietary carbohydrate restriction in type 2 diabetes mellitus and metabolic syndrome: time for a critical appraisal
Q34983044Dietary epicatechin promotes survival of obese diabetic mice and Drosophila melanogaster
Q35949722Efficacy of various antidiabetic agents as add-on treatments to metformin in type 2 diabetes mellitus: systematic review and meta-analysis.
Q42153827Global gene expression profiling displays a network of dysregulated genes in non-atherosclerotic arterial tissue from patients with type 2 diabetes
Q36935873Lifetime body mass index and later atherosclerosis risk in young adults: examining causal links using Mendelian randomization in the Cardiovascular Risk in Young Finns study
Q34485920Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice
Q37494520Pathogenesis and pathophysiology of accelerated atherosclerosis in the diabetic heart.
Q42946155Protein tyrosine phosphatase PTPεM negatively regulates PDGF β-receptor signaling induced by high glucose and PDGF in vascular smooth muscle cells
Q90164224Statin prescription among patients with type 2 diabetes in Botswana: findings and implications

Search more.